Mirova US LLCMirova US LLC

Institutional investor · Portfolio as of Q4 2019

Top Holdings32 positions

Checking export access…
Activity:

MICROSOFT CORP

458,815$72.4M9.8%$148.790.00%
1 qtr
First report
0

MASTERCARD INC

234,664$70.1M9.5%$287.290.00%
1 qtr
First report
0

Thermo Fisher Scientific Inc

203,773$66.2M9.0%$318.980.00%
1 qtr
First report
0

DANAHER CORPORATION

388,195$59.6M8.1%$131.770.00%
1 qtr
First report
0

Ecolab Inc.

266,955$51.5M7.0%$179.560.00%
1 qtr
First report
0

VISA INC

257,196$48.3M6.5%$179.020.00%
1 qtr
First report
0

EBAY INC

1.3M$47.3M6.4%$32.330.00%
1 qtr
First report
0

Roper Technologies Inc

130,816$46.3M6.3%$342.890.00%
1 qtr
First report
0

ALPHABET INC

31,496$42.2M5.7%$66.340.00%
1 qtr
First report
0

AMERICAN WTR WKS CO INC NEW

310,389$38.1M5.2%$107.440.00%
1 qtr
First report
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

626,942$36.4M4.9%$51.640.00%
1 qtr
First report
0

ADOBE INC

97,123$32M4.3%$328.340.00%
1 qtr
First report
0

NextEra Energy Inc

109,551$26.5M3.6%$51.080.00%
1 qtr
First report
0

GILEAD SCIENCES INC

315,040$20.5M2.8%$51.500.00%
1 qtr
First report
0

SIGNATURE BK NEW YORK N Y

143,900$19.7M2.7%——
1 qtr
First report
0

LAUDER ESTEE COS INC

87,122$18M2.4%$190.780.00%
1 qtr
First report
0

WATTS WATER TECHNOLOGIES INC

139,126$13.9M1.9%$94.580.00%
1 qtr
First report
0

Oracle Corp.

255,277$13.5M1.8%$48.100.00%
1 qtr
First report
0

NVIDIA CORPORATION

13,173$3.1M0.4%$5.840.00%
1 qtr
First report
0

Intuitive Surgical Inc.

4,770$2.8M0.4%$197.050.00%
1 qtr
First report
0
$738.4M
AUM
32
Positions
Q4 2019
Filing
HI score · 4.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q4'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

Mirova US LLC manages $738.4M across 32 positions as of Q4 2019. Top holdings: MSFT (9.8%), MA (9.5%), TMO (9.0%). Fund DNA: Steady Compounder. HoldingsIntel Score: 4/5.0.

Q4 2019 Summary

First quarter we have for this fund: 32 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $738M across 32 positions.

Top holdings by portfolio weight

Total AUM$738M
MSFT9.80%
MA9.49%
TMO8.97%
DHR8.07%
ECL6.98%
V6.55%
EBAY6.40%
ROP6.28%
GOOGL5.71%
AWK5.16%
Other4.93%

Portfolio allocation by GICS sector

Sectors10
Technology27.60%
Healthcare20.20%
Financial Services18.70%
Utilities9.03%
Basic Materials7.12%
Consumer Cyclical6.74%
Communication Services5.82%
Consumer Defensive2.44%
Industrials2.34%
Unknown0.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Financial Services
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Strong(4.0 / 5.0)
Holdings P&L71
Conviction53
Concentration73
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
BSXBSXBoston Scientific Corporation
Q1 2026 → Q2 2026+1.7M shares+$1.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used